Suchergebnisse - "Disease-modifying antirheumatic drugs"

PubPharm (1.212)

1

Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection : Across-sectional study

enthalten in: International journal of rheumatic diseases | 2024

von Zhang, Y. | Xu, P. | Huang, J. | +1

2

Adherence, persistence and treatment switching in psoriasis

enthalten in: Immunotherapy | 2024

von Santoleri, F. | Musicco, F. | Fulgenzio, C. | +25

3

Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2024

von Giles, J. | Solomon, D. | Liao, K. | +4

4

The temporal association between adverse drug reactions and antirheumatic drugs utilisation in Western Australia : a retrospective study from real-world data (1995-2015)

enthalten in: Rheumatology international | 2024

von Almutairi, K. | Inderjeeth, C. | Preen, D. | +2

5

When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?

enthalten in: European journal of pediatrics | 2024

von Polat, M. | Çelikel, E. | Tekin, Z. | +10

6

Drug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis : results from a nationwide cross-sectional online survey

enthalten in: Rheumatology international | 2024

von Asmar, S. | Messaykeh, J. | Hilal, N. | +6

7

Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Birkner, B. | Rech, J. | Edelmann, E. | +3

8

Rheumatoid arthritis and risk of osteoarticular infection and death following Staphylococcus aureus bacteraemia : A nationwide cohort study

enthalten in: Rheumatology (Oxford, England) | 2024

von Dieperink, S. | Nørgaard, M. | Mehnert, F. | +6

9

Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis : The ANSWER cohort study

enthalten in: International journal of rheumatic diseases | 2024

von Shirasugi, I. | Onishi, A. | Nishimura, K. | +21

10

Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis

enthalten in: Seminars in arthritis and rheumatism | 2024

von McDermott, G. | DiIorio, M. | Kawano, Y. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[122]